Lakewood-Amedex Biotherapeutics Announces IRB Approval and Clinical Site Readiness to Initiate Phase 2a Clinical Trial of Nu-3 for the Treatment of Infected Diabetic Foot Ulcers
PR Newswire•18/09/2026•08:14 ET
0
Get started
Create a free account to read the full story and Whiz Insights.